Analyst Ratings For Charles River Laboratories International (NYSE:CRL)
Today, Royal Bank of Canada initiated coverage on Charles River Laboratories International (NYSE:CRL) with a Sector Perform with a price target of $110.00.
There are 5 hold ratings, 4 buy ratings on the stock.
The current consensus rating on Charles River Laboratories International (NYSE:CRL) is Hold (Score: 2.44) with a consensus target price of $100.17 per share, a potential 5.22% downside.
Some recent analyst ratings include
- 9/19/2017-Royal Bank of Canada initiated coverage with a Sector Perform rating.
- 9/12/2017-Jefferies Group LLC Reiterated Rating of Buy.
- 9/1/2017-Robert W. Baird Reiterated Rating of Buy.
- 7/19/2017-Barclays PLC Reiterated Rating of Hold.
- 6/28/2017-Citigroup Inc. Reiterated Rating of Neutral.
- 6/6/2017-Credit Suisse Group Reiterated Rating of Neutral.
- 1/4/2017-Evercore ISI Upgrade from a “Hold ” rating to a ” Buy” rating.
Recent Insider Trading Activity For Charles River Laboratories International (NYSE:CRL)
Charles River Laboratories International (NYSE:CRL) has insider ownership of 2.20% and institutional ownership of 95.37%.
- On 9/5/2017 Davide Molho, Insider, sold 5,982 with an average share price of $107.55 per share and the total transaction amounting to $643,364.10. View SEC Filing
- On 8/17/2017 William D Barbo, Insider, sold 4,000 with an average share price of $99.91 per share and the total transaction amounting to $399,640.00. View SEC Filing
- On 8/14/2017 David Ross Smith, Insider, sold 2,552 with an average share price of $67.10 per share and the total transaction amounting to $171,239.20. View SEC Filing
- On 7/17/2017 George Massaro, Director, sold 3,830 with an average share price of $100.81 per share and the total transaction amounting to $386,102.30. View SEC Filing
- On 7/10/2017 James C Foster, Chairman, sold 9,516 with an average share price of $98.92 per share and the total transaction amounting to $941,322.72. View SEC Filing
- On 6/22/2017 Davide Molho, Insider, sold 10,948 with an average share price of $100.00 per share and the total transaction amounting to $1,094,800.00. View SEC Filing
- On 6/22/2017 James C Foster, Chairman, sold 43,154 with an average share price of $100.00 per share and the total transaction amounting to $4,315,400.00. View SEC Filing
Recent Trading Activity for Charles River Laboratories International (NYSE:CRL)
Shares of Charles River Laboratories International closed the previous trading session at with shares trading hands.